phase readout
saveNCT02410733: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Melanoma
view source ↗
comments(0)
5-min edit window · permanent after that